Role of peroxisome proliferator-activated receptor γ and its ligands in non-neoplastic and neoplastic human urothelial cells

American Journal of Pathology

Volumn 159, Issue 2, 2001, Pages 591-597

  Nakashiro, K I ^a   Hayashi, Y ^a   Kita, A ^a   Tamatani, T ^a   Chlenski, A ^a   Usuda, N ^a   Hattori, K ^a   Reddy, J K ^a   Oyasu, R ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA12 PROSTAGLANDIN J2; LIGAND; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TROGLITAZONE;

ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CELL LINE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0034880165     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61730-0     Document Type: Article

References (28)

1. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
2. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
3. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
4. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rats
5. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
6. Differential expression of the peroxisome proliferator-activated receptor γ (PPARγ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse
7. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
8. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
9. Terminal differentiation of human breast cancer through PPARγ
10. Ligand for peroxisome proliferator-activated receptor γ (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
11. Differentiation and reversal of malignant changes in colon cancer through PPARγ
12. min/+mice
13. Activators of the nuclear receptor PPARγ enhance colon polyp formation
14. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
15. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ
16. 2 in human urine
17. Tissue culture model of transitional cell carcinoma: Characterization of twenty-two human urothelial cell lines
18. 2-generating peroxisomal fatty acyl CoA oxidase
19. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro
20. Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo
21. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
22. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ
23. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells
24. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
25. Loss-of-function mutations in PPARγ associated with human colon cancer
26. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
27. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkB kinase